Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

BACKGROUND: Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS (cfKRAS(mut)) and CA 19–9 during adjuvan...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Hussung, Saskia, Akhoundova, Dilara, Hipp, Julian, Follo, Marie, Klar, Rhena F. U., Philipp, Ulrike, Scherer, Florian, von Bubnoff, Nikolas, Duyster, Justus, Boerries, Melanie, Wittel, Uwe, Fritsch, Ralph M.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802224/
https://ncbi.nlm.nih.gov/pubmed/33430810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07736-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares